Phoenix researcher was recently awarded a $1.9 million National Institutes of Health grant to study the molecular mechanisms of how dilated cardiomyopathy progresses to heart failure, which could ...

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of ...

NIH grant fuels research to find improved treatments for heart failure, aiming to advance care and enhance outcomes for ...

Better imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...

This study used dilated cardiomyopathy data from the OpenGWAS ... Overall, the findings pave the way for metabolite-centered precision prevention and treatment strategies. Finally, this work ...

In several families with X linked dilated cardiomyopathy, the pattern of expression of dystrophin mutations in cardiac muscle differs from that in skeletal muscle. A number of these mutations affect ...

The claims detail the potential benefits of this treatment, including improvements in physical performance as measured by the six-minute walk test, stabilization of walking distance, and a reduction ...

View all available purchase options and get full access to this article. Victor Chang Cardiac Research Institute, Darlinghurst, Australia (J.-L.M.T., R.J., M.T., E.M ...

Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

Background: A 56-year-old man with normal cardiac function received treatment with interferon ... Diagnosis: Interferon α-2b-induced cardiomyopathy. Management: Intravenous dobutamine and ...

aEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, 21040-360, Brazil bDepartment of Research and Education, National Institute of Cardiology, Rio de ...